Latest News and Press Releases

Results Driven by 49% Growth in Revenue Adjusted EPS Growth of 10% Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. ET ROCKVILLE, Md., Aug. 03, 2016 (GLOBE...

ROCKVILLE, Md., July 29, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Paul Edick will join Sucampo's...

ROCKVILLE, Md., July 20, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter...

ROCKVILLE, Md., July 11, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the decision to discontinue the...

ROCKVILLE, Md., July 08, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...

ROCKVILLE, Md., May 31, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...

ROCKVILLE, Md., May 17, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...

Results Driven by 60% Growth in Revenue Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. EDT ROCKVILLE, Md., May 04, 2016 (GLOBE NEWSWIRE) -- Sucampo...

ROCKVILLE, Md., May 03, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...

ROCKVILLE, Md., April 20, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter...